Trial Profile
Comparative study between effects of insulin degludec and glargine U300 on nighttime blood glucose fluctuation -Investigasion using flash glucose monitoring system-
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Sep 2018
Price :
$35
*
At a glance
- Drugs Insulin degludec (Primary) ; Insulin glargine (Primary)
- Indications Diabetes mellitus
- Focus Therapeutic Use
- 07 Sep 2018 Status changed from recruiting to completed.
- 05 Jun 2017 New trial record